“…In clinical studies of subcutaneous aeroallergen immunotherapy for allergic rhinitis, increases in specific IgG "blocking" antibodies are strongly correlated with effective desensitization (Akdis, Barlan, Bahceciler, & Akdis, 2006;James et al, 2011;Lichtenstein, Holtzman, & Burnett, 1968). Similar relationships between antigen-specific IgG induction and efficacy of desensitization have been observed in OIT trials for food allergy (Bedoret et al, 2012;Caubet et al, 2012;Jones et al, 2009;Kim et al, 2011;Skripak et al, 2008;Vickery et al, 2013Vickery et al, , 2014. As previously observed for aeroallergen immunotherapy, induction of the IgG4 isotype has emerged as the best clinical correlate for desensitization.…”